Makers Laboratories Ltd. logo

Makers Laboratories Ltd. (MAKERSL)

Market Closed
11 Aug, 22:00
MSE MSE
159. 40
+0.55
+0.3462%
896.56M Market Cap
134.75 P/E Ratio
- Div Yield
510 Volume
0 Eps
158.85
Previous Close
Add Transaction
Day Range
154.1 160
Year Range
109 186.7
Want to track MAKERSL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MAKERSL closed today higher at ₹159.4, an increase of 0.3462% from yesterday's close, completing a monthly increase of 7.1236% or ₹10.6. Over the past 12 months, MAKERSL stock gained 29.1211%.
MAKERSL is not paying dividends to its shareholders.
The last earnings report, released on May 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Makers Laboratories Ltd. has completed 1 stock splits, with the recent split occurring on Mar 30, 2022.
The company's stock is traded on one exchange.

MAKERSL Chart

People also search for

Oxygenta Pharmaceutical Ltd.
65.64
+17.6344%
Tyche Industries Ltd.
126.3
+0.2779%
DHP India Ltd.
516
-1.7049%
Parnax Lab Ltd.
133
0%
Simmonds Marshall Ltd.
193
-0.4642%

Makers Laboratories Ltd. (MAKERSL) FAQ

What is the stock price today?

The current price is ₹159.40.

On which exchange is it traded?

Makers Laboratories Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is MAKERSL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 896.56M.

Has Makers Laboratories Ltd. ever had a stock split?

Makers Laboratories Ltd. had 1 splits and the recent split was on Mar 30, 2022.

Makers Laboratories Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Saahil U. Parikh CEO
MSE Exchange
INE987A01010 ISIN
India Country
131 Employees
1 Aug 2019 Last Dividend
- Last Split
- IPO Date
Makers Laboratories Ltd. is a prominent pharmaceutical company involved in manufacturing, distribution, and marketing of a diverse range of medicinal products. The primary purpose of the company is to produce and supply high-quality pharmaceutical formulations across various therapeutic segments. With a strong focus on human and veterinary medicine, Makers Laboratories Ltd. plays a crucial role in enhancing healthcare solutions in both domestic and international markets. The company is notable for its vast product portfolio, which includes antibiotics, pain management drugs, cardiovascular medications, and drugs for respiratory conditions, among others. This diversification allows Makers Laboratories Ltd. to cater to a wide array of healthcare needs, covering several critical areas in the medical field. In the broader financial market, Makers Laboratories Ltd. holds a significant position by contributing to advancements in the pharmaceutical industry. Its operations support the global healthcare infrastructure, ensuring the availability of essential medicines. By continuously investing in research and development, the company stays at the forefront of pharmaceutical innovation, meeting the ever-evolving needs of patients and healthcare providers.

Contact Information

Address: 54-D, Kandivli Industrial Estate
Phone: 91 22 2868 8544